Drug Discovery & Development | BioInvent, Bayer Extend Therapeutic Antibodies Collaboration Drug Discovery & Development BioInvent International AB announced that it has signed an extension to its 2008 license agreement with Bayer Pharma AG for the development of antibodies from BioInvent's n-CoDeR libraries. Under the terms of the extension, Bayer will broaden its ... BioInvent and Bayer extend and broaden collaboration for the discovery and ... |
